PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 352 (xsd:integer)
nif:isString
  • We estimated the number of participants needed to reject the null hypothesis (no difference between valerian and placebo) for the primary analysis for proportions from 0.15 to 0.40 in the placebo group and absolute improvements of 10 to 25% based on Pearson Chi-square 2-sided tests for two proportions, with a significance level of 0.05 and 80% power.
rdf:type